[HTML][HTML] Synthesis of biologically active molecules through multicomponent reactions

D Insuasty, J Castillo, D Becerra, H Rojas, R Abonia - Molecules, 2020 - mdpi.com
Focusing on the literature progress since 2002, the present review explores the highly
significant role that multicomponent reactions (MCRs) have played as a very important tool …

Therapeutic evolution of benzimidazole derivatives in the last quinquennial period

W Akhtar, MF Khan, G Verma… - European journal of …, 2017 - Elsevier
Benzimidazole, a fused heterocycle bearing benzene and imidazole has gained
considerable attention in the field of contemporary medicinal chemistry. The moiety is of …

[HTML][HTML] New tuberculosis drug targets, their inhibitors, and potential therapeutic impact

GS Shetye, SG Franzblau, S Cho - Translational Research, 2020 - Elsevier
The current tuberculosis (TB) predicament poses numerous challenges and therefore every
incremental scientific work and all positive socio-political engagements, are steps taken in …

[HTML][HTML] Tuberculosis drug discovery: A decade of hit assessment for defined targets

S Oh, L Trifonov, VD Yadav, CE Barry III… - Frontiers in Cellular …, 2021 - frontiersin.org
More than two decades have elapsed since the publication of the first genome sequence of
Mycobacterium tuberculosis (Mtb) which, shortly thereafter, enabled methods to determine …

Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis

SJ Tantry, SD Markad, V Shinde, J Bhat… - Journal of medicinal …, 2017 - ACS Publications
The approval of bedaquiline to treat tuberculosis has validated adenosine triphosphate
(ATP) synthase as an attractive target to kill Mycobacterium tuberculosis (Mtb). Herein, we …

Design, synthesis, and biological evaluation of benzo [d] imidazole-2-carboxamides as new anti-TB agents

TM Dhameliya, KI Patel, R Tiwari, SK Vagolu… - Bioorganic …, 2021 - Elsevier
Tuberculosis is the leading cause of death globally among infectious diseases. Due to the
development of resistance of Mycobacterium tuberculosis to currently used anti-TB …

[HTML][HTML] Oxidative Phosphorylation—an Update on a New, Essential Target Space for Drug Discovery in Mycobacterium tuberculosis

CSY Foo, K Pethe, A Lupien - Applied Sciences, 2020 - mdpi.com
New drugs with new mechanisms of action are urgently required to tackle the global
tuberculosis epidemic. Following the FDA-approval of the ATP synthase inhibitor …

Discovery and optimization of novel biphenyl derivatives bearing cyclopropyl linkage as potent programmed cell death-1/programmed cell death-ligand 1 inhibitors

T Jing, Z Zhang, Z Kang, J Mo, X Yue… - Journal of Medicinal …, 2023 - ACS Publications
A series of novel compounds bearing a cyclopropyl linkage were designed, synthesized,
and evaluated as programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) …

Synthesis, molecular docking and biological evaluation of some benzimidazole derivatives as potent pancreatic lipase inhibitors

E Menteşe, F Yılmaz, M Emirik, S Ülker, B Kahveci - Bioorganic Chemistry, 2018 - Elsevier
In this study, a new series of benzimidazole and bisbenzimidazole derivatives were
prepared via the reaction of iminoester hydrochlorides and o-phenylenediamines and then …

Synthesis and molecular docking study of some 5, 6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as …

E Menteşe, H Bektaş, BB Sokmen, M Emirik… - Bioorganic & medicinal …, 2017 - Elsevier
A new series of benzimidazole compounds including hydrazinecarbothioamide, 1, 2, 4-
triazole, 1, 3, 4-oxadiazole and imine function were synthesized starting from 5, 6-dichloro-2 …